Checkpoint Capital »

Protagonist Therapeutics shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 355k 34.65
2024-03-31 $8.1M 280k 28.93
2023-12-31 $6.1M 267k 22.93